Advertisement

Elanco Company Profile

05:18 EDT 19th May 2013 | BioPortfolio

Elanco is a global innovation-driven company that develops and markets products to improve animal health and food animal production in more than 100 countries. Elanco employs more than 2,000 people worldwide, with offices in more than 30 countries, and is a division of Eli Lilly and Company, a leading global pharmaceutical corporation. Additional information about Elanco is available at www.elanco.com.


News Articles [ 10 Associated News Articles listed on BioPortfolio]

Lilly Invests $100 Million in China Animal Healthcare Ltd.

Eli Lilly’s animal health division, Elanco, will make a $100 million investment into China Animal Healthcare Ltd. The capital, which will give Elanco a 20% stake in China Animal Health, will be...

Lilly's Elanco Buys $100 Million Minority Stake In China Animal Healthcare

Eli Lilly's Elanco animal-health unit said it would buy a $100 million stake in China Animal Healthcare, subject to conditions, to boost innovation in food production.

China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcare

By ChinaBio Today: Deals and Financings Eli Lilly's (NYSE: LLY) animal health division, Elanco, will make a $100 million investment into China Animal Healthcare Ltd. (SG: CAL; HK: 940) (see story)...

Elanco's Consumer Advertising Campaign Raises Heartworm Awareness

GREENFIELD, Ind., May 25, 2012 /PRNewswire/ -- Elanco Companion Animal Health's national consumer advertising campaign for Trifexis® (spinosad + milbemycin oxime) and its first television commerc...

Elanco Announces Comfortis® (spinosad) for Cats and Small Dogs

Comfortis® (spinosad), the month-long flavored tablet that has been protecting dogs from fleas since 2007 has now been approved for use in cats and smaller dogs. As a result of t...

Vetoquinol Names Dr. Eric M. Alsup as Country Manager, USA

FORT WORTH, Texas, April 3, 2013 /PRNewswire/ -- Vetoquinol USA announces the appointment of Dr. Eric M. Alsup as country manager for Vetoquinol USA. Alsup will replace Daniel Beauchamp, who is l...

Lorus Therapeutics Signs Research and License Option Agreement with Elanco

TORONTO, ONTARIO -- (Marketwired) -- 04/17/13 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical p...

Livestock Biotech Summit Draws International Crowd

On September 19, BIO’s Livestock Biotech Summit kicked off with an international flair. Eleven countries are represented at the Kansas City conference including Argentina, Belgium, China, Italy an...

Drugs and Medications [0 Results]

None

PubMed Articles [ 6 Associated PubMed Articles listed on BioPortfolio]

Current infection patterns of porcine proliferative enteropathy in Great Britain and the Republic of Ireland.

Oral administration of lanthanum dioxycarbonate does not alter bone morphology of normal cats.

Safety and efficacy of spinosad chewable tablets for treatment of flea infestations of cats.

Objective-To compare safety and efficacy of spinosad and selamectin and determine effects of those products on flea allergy dermatitis (FAD) in cats. Design-Randomized clinical trial. Animals-211 clie...

Dose confirmation and non-interference evaluations of the oral efficacy of a combination of milbemycin oxime and spinosad against the dose limiting parasites, adult cat flea (Ctenocephalides felis) and hookworm (Ancylostoma caninum), in dogs.

Two separate controlled and blinded studies were conducted to confirm the dose and non-interference of spinosad and milbemycin oxime (MO) administered orally in combination or alone to dogs for the tr...

Confirmation of the efficacy of a combination tablet of spinosad and milbemycin oxime against naturally acquired infections of canine intestinal nematode parasites.

Four separate controlled and blinded studies were conducted to confirm the dose of spinosad and milbemycin oxime (MO) administered orally in combination to dogs for the treatment and control of natura...

Clinical Trials [0 Results]

None

Companies [ 3 Associated Companies listed on BioPortfolio]

Elanco

Elanco is a global innovation-driven company that develops and markets products to improve animal health and food animal production in more than 100 countries. Elanco employs more than 2,000 peopl...

Elanco Animal Health

Elanco is a global research-based company that develops and markets products to improve the health and production of animals in more than 100 countries. Elanco is a division of Eli Lilly and Company,...

Elanco Companion Animal Health

More Information about "Elanco" on BioPortfolio

We have published hundreds of Elanco news stories on BioPortfolio along with dozens of Elanco Clinical Trials and PubMed Articles about Elanco for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elanco Companies in our database. You can also find out about relevant Elanco Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement